Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;33(3):217-23.
doi: 10.1055/s-0036-1586142.

Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review

Affiliations
Review

Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review

Matthew Ryan Macey et al. Semin Intervent Radiol. 2016 Sep.

Abstract

Benign prostatic hyperplasia (BPH) with lower urinary tract symptoms (LUTS) is one of the most common ailments affecting aging men. Symptoms typically associated with BPH include weak stream, hesitancy, urgency, frequency, and nocturia. More serious complications of BPH include urinary retention, gross hematuria, bladder calculi, recurrent urinary tract infection, obstructive uropathy, and renal failure. Evaluation of BPH includes a detailed history, objective assessment of urinary symptoms with validated questionnaires, and measurement of bladder function parameters, including uroflowmetry and postvoid residual. In general, treatment of LUTS associated with BPH is based on the effect of the symptoms on quality of life (QOL) and include medical therapy aimed at reducing outlet obstruction or decreasing the size of the prostate. If medical therapy fails or is contraindicated, various surgical options exist. As the elderly population continues to grow, the management of BPH will become more common and important in maintaining patient's QOL.

Keywords: benign prostatic hyperplasia; interventional radiology; lower urinary tract symptoms; transurethral resection of the prostate.

PubMed Disclaimer

References

    1. Lee C, Kozlowski J M, Grayhack J T. Intrinsic and extrinsic factors controlling benign prostatic growth. Prostate. 1997;31(2):131–138. - PubMed
    1. Auffenberg G B Helfand B T McVary K T Established medical therapy for benign prostatic hyperplasia Urol Clin North Am 2009364443–459., v–vi - PubMed
    1. Reynard J M. Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents? Curr Opin Urol. 2004;14(1):13–16. - PubMed
    1. Wei J T, Calhoun E, Jacobsen S J. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2005;173(4):1256–1261. - PubMed
    1. McVary K BPH: epidemiology and comorbidities Am J Manag Care 200612(5 Suppl): S122–S128. - PubMed